Abstract
Hepatitis B virus (HBV) infection remains a major health concern with more than 350 million carriers in the world. It is associated with acute and chronic liver diseases including hepatocellular carcinoma (HCC). The early detection of severe liver diseases related to HBV is crucial for the effective treatment. This work aims to investigate the secreted proteins in our recently established cell-based HBV replication system, using isobaric tags for relative and absolute quantitation (iTRAQ)-coupled 2D LC–MS/MS proteomics approach. Such proteins are reflective of early events of HBV infection and thus may have potential as prognostic biomarkers for development of liver diseases.
Similar content being viewed by others
References
Blumberg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I et al (1975) The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 81:669–682
Cho WC (2007) Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6:25
Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56:651–693
Hong P, Ng LF, Ren EC, Chen WN (2005) A cell-based system for hepatitis B virus replication: significance of clinically enhanced viral replication in relation to deletions in viral core promoter. Front Biosci 10:2001–2004
Jiang J, Zhang X, Wu C, Qin X, Luo G, Deng H et al (2008) Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases. Lipids Health Dis 7:25
Kalabay L, Jakab L, Prohaszka Z, Fust G, Benko Z, Telegdy L et al (2002) Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. Eur J Gastroenterol Hepatol 14:389–394
Kalabay L, Graf L, Voros K, Jakab L, Benko Z, Telegdy L et al (2007) Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores. BMC Gastroenterol 7:15
Kawakami T, Hoshida Y, Kanai F, Tanaka Y, Tateishi K, Ikenoue T et al (2005) Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. Proteomics 5:4287–4295
Kurebayashi J (2004) Biomarkers in breast cancer. Gan To Kagaku Ryoho 31:1021–1026
Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64:51–68
Steel LF, Shumpert D, Trotter M, Seeholzer SH, Evans AA, London WT et al (2003) A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3:601–609
Sui J, Zhang J, Tan TL, Ching CB, Chen WN (2008) Comparative proteomics analysis of vascular smooth muscle cells incubated with S- and R-enantiomers of atenolol using iTRAQ-coupled two-dimensional LC-MS/MS. Mol Cell Proteomics 7:1007–1018
Sui J, Zhang J, Ching CB, Chen WN (2008) Comparative proteomic analysis of extracellular proteins reveals secretion of T-kininogen from vascular smooth muscle cells in response to incubation with s-enantiomer of propranolol. Mol Pharm 5:885–890
Yokoyama Y, Kuramitsu Y, Takashima M, Iizuka N, Terai S, Oka M et al (2006) Protein level of apolipoprotein E increased in human hepatocellular carcinoma. Int J Oncol 28:625–631
Acknowledgments
This work was supported by Grant RG42/05 (WN Chen). Huixing Feng and Mingxuan Wang are recipients of graduate research scholarship from Nanyang Technological University, Singapore. We thank Jianjun Sui for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feng, H., Wang, M. & Chen, W.N. iTRAQ-Coupled 2D LC–MS/MS Analysis of Secreted Proteome of HBV-Replicating HepG2 Cells: Potential in Biomarkers for Prognosis of HCC. Curr Microbiol 61, 280–284 (2010). https://doi.org/10.1007/s00284-010-9608-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-010-9608-3